
    
      If eligible and informed consent obtained, patients will be randomized 1:1:1 into one of the
      following 3 arms, to receive:

        1. Standard of Care (SoC) TB treatment + placebo twice daily during the first 4 weeks of TB
           treatment followed by placebo once daily for an additional 4 weeks. (control group).

        2. SoC TB treatment + acetylsalicylic acid 300mg twice daily during the first 4 weeks of TB
           treatment followed by acetylsalicylic acid 300mg once daily for an additional 4 weeks.

        3. SoC TB treatment + ibuprofen 400mg twice daily during the first 4 weeks of TB treatment
           followed by ibuprofen 400mg once daily for an additional 4 weeks.
    
  